Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current revenue (TTM) is $15.05 B. In 2022 the company made a revenue of $15.11 B an increase over the years 2021 revenue that were of $12.78 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $15.05 B | -0.38% |
2022 | $15.11 B | 18.22% |
2021 | $12.78 B | 9.52% |
2020 | $11.67 B | 2.74% |
2019 | $11.36 B | 2.11% |
2018 | $11.12 B | 5.36% |
2017 | $10.56 B | 3.92% |
2016 | $10.16 B | -20.27% |
2015 | $12.74 B | -24.5% |
2014 | $16.88 B | 10.65% |
2013 | $15.25 B | 7.53% |
2012 | $14.19 B | 2.14% |
2011 | $13.89 B | 6.41% |
2010 | $13.05 B | 3.93% |
2009 | $12.56 B | 1.73% |
2008 | $12.34 B | 9.63% |
2007 | $11.26 B | 8.53% |
2006 | $10.37 B | 5.37% |
2005 | $9.84 B | 3.58% |
2004 | $9.50 B | 6.65% |
2003 | $8.91 B | 9.94% |
2002 | $8.11 B | 5.83% |
2001 | $7.66 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Medtronic MDT | $30.77 B | 104.40% | ๐ฎ๐ช Ireland |
![]() Thermo Fisher Scientific TMO | $43.80 B | 190.98% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $18.80 B | 24.94% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | $13.04 B | -13.35% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $18.95 B | 25.89% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | $198.66 B | 1,219.57% | ๐บ๐ธ USA |
![]() ICU Medical
ICUI | $2.30 B | -84.69% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | $0.70 B | -95.32% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | $10.07 B | -33.10% | ๐บ๐ธ USA |
![]() CryoLife CRY | $0.29 B | -98.02% | ๐บ๐ธ USA |